Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annabel Dawson"'
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Introduction Selecting and collecting data to support appropriate primary and secondary outcomes is a critical step in designing trials that can change clinical practice. In this study, we aimed to investigate who contributes to the process
Externí odkaz:
https://doaj.org/article/9eb00c4960314ebfa1388724d9c19e7f
Autor:
Heidi Gardner, Adel Elfeky, David Pickles, Annabel Dawson, Katie Gillies, Violet Warwick, Shaun Treweek
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Data collection is a substantial part of trial workload for participants and staff alike. How these hours of work are spent is important because stakeholders are more interested in some outcomes than others. The ORINOCO study comp
Externí odkaz:
https://doaj.org/article/2fa0de7bb9ed4dacae2c2c7030ec059d
Introduction Selecting and collecting data to support appropriate primary and secondary outcomes is a critical step in designing trials that can change clinical practice. In this study, we aimed to investigate who contributes to the process of select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73713149d08a7385f417801401a61343
https://doi.org/10.21203/rs.3.rs-2371475/v1
https://doi.org/10.21203/rs.3.rs-2371475/v1
Autor:
Qiukui Hao, Bert Aertgeerts, Gordon Guyatt, Geertruida E Bekkering, Per Olav Vandvik, Safi U Khan, Nicolas Rodondi, Rod Jackson, Jean-Luc Reny, Lubna Al Ansary, Mieke Van Driel, Willem J J Assendelft, Thomas Agoritsas, Frederick Spencer, Reed A C Siemieniuk, Lyubov Lytvyn, Anja Fog Heen, Qian Zhao, Irbaz Bin Riaz, Dirk Ramaekers, Patrick Mba Okwen, Ye Zhu, Annabel Dawson, Mersa Caius Ovidiu, Willy Vanbrabant, Sheyu Li, Nicolas Delvaux
Publikováno v:
Bmj. British Medical Journal (Compact Ed.), 377
Clinical questionIn adults with low density lipoprotein (LDL) cholesterol levels >1.8 mmol/L (>70 mg/dL) who are already taking the maximum dose of statins or are intolerant to statins, should another lipid-lowering drug be added, either a proprotein